RESUMEN
In 2014, the National Institutes of Health (NIH) initiated the Illuminating the Druggable Genome (IDG) program to identify and improve our understanding of poorly characterized proteins that can potentially be modulated using small molecules or biologics. Two resources produced from these efforts are: The Target Central Resource Database (TCRD) (http://juniper.health.unm.edu/tcrd/) and Pharos (https://pharos.nih.gov/), a web interface to browse the TCRD. The ultimate goal of these resources is to highlight and facilitate research into currently understudied proteins, by aggregating a multitude of data sources, and ranking targets based on the amount of data available, and presenting data in machine learning ready format. Since the 2017 release, both TCRD and Pharos have produced two major releases, which have incorporated or expanded an additional 25 data sources. Recently incorporated data types include human and viral-human protein-protein interactions, protein-disease and protein-phenotype associations, and drug-induced gene signatures, among others. These aggregated data have enabled us to generate new visualizations and content sections in Pharos, in order to empower users to find new areas of study in the druggable genome.
Asunto(s)
Bases de Datos Factuales , Genoma Humano , Enfermedades Neurodegenerativas/genética , Proteómica/métodos , Programas Informáticos , Virosis/genética , Animales , Anticonvulsivantes/química , Anticonvulsivantes/uso terapéutico , Antivirales/química , Antivirales/uso terapéutico , Productos Biológicos/química , Productos Biológicos/uso terapéutico , Minería de Datos/estadística & datos numéricos , Interacciones Huésped-Patógeno/efectos de los fármacos , Interacciones Huésped-Patógeno/genética , Humanos , Internet , Aprendizaje Automático/estadística & datos numéricos , Ratones , Ratones Noqueados , Terapia Molecular Dirigida/métodos , Enfermedades Neurodegenerativas/clasificación , Enfermedades Neurodegenerativas/tratamiento farmacológico , Enfermedades Neurodegenerativas/virología , Mapeo de Interacción de Proteínas , Proteoma/agonistas , Proteoma/antagonistas & inhibidores , Proteoma/genética , Proteoma/metabolismo , Bibliotecas de Moléculas Pequeñas/química , Bibliotecas de Moléculas Pequeñas/uso terapéutico , Virosis/clasificación , Virosis/tratamiento farmacológico , Virosis/virologíaRESUMEN
OBJECTIVE: Ascertain the optimal interaction scoring criteria for the Computational Analysis of Novel Drug Opportunities (CANDO) platform for shotgun drug repurposing to improve benchmarking performance, thereby enabling more accurate prediction of novel therapeutic drug-indication pairs. RESULTS: We have investigated and enhanced the interaction scoring criteria in the bioinformatic docking protocol in the newest version of our platform (v1.5), with the best performing interaction scoring criterion yielding increased benchmarking accuracies from 11.7% in v1 to 12.8% in v1.5 at the top10 cutoff (the most stringent one) and correspondingly from 24.9 to 31.2% at the top100 cutoff.
Asunto(s)
Biología Computacional/estadística & datos numéricos , Descubrimiento de Drogas/métodos , Reposicionamiento de Medicamentos/métodos , Medicamentos bajo Prescripción/química , Proteoma/química , Programas Informáticos , Sitios de Unión , Reposicionamiento de Medicamentos/estadística & datos numéricos , Humanos , Simulación del Acoplamiento Molecular , Medicamentos bajo Prescripción/farmacología , Unión Proteica , Conformación Proteica , Proteoma/agonistas , Proteoma/antagonistas & inhibidoresRESUMEN
BACKGROUND: Synthesis of silver nano-compounds with enhanced antimicrobial effects is of great interest for the development of new antibacterial agents. Previous studies have reported the antibacterial properties of pegylated silver-coated carbon nanotubes (pSWCNT-Ag) showing less toxicity in human cell lines. However, the mechanism underlining the pSWCNT-Ag as a bactericidal agent remained unfolded. Here we assessed the pSWCNT-Ag effects against foodborne pathogenic bacteria growth and proteome profile changes. RESULTS: Measurements of bioluminescent imaging, optical density, and bacteria colony forming units revealed dose-dependent and stronger bactericidal activity of pSWCNT-Ag than their non-pegylated counterparts (SWCNT-Ag). In ovo administration of pSWCNT-Ag or phosphate-buffered saline resulted in comparable chicken embryo development and growth. The proteomic analysis, using two-dimensional electrophoresis combined with matrix assisted laser desorption/ionization time of flight/time of flight mass spectrometry, was performed on control and surviving Salmonella enterica serovar Typhimurium to pSWCNT-Ag. A total of 15 proteins (ten up-regulated and five down-regulated) differentially expressed proteins were identified. Functional analyses showed significant reduction of proteins associated with biofilm formation, nutrient and energy metabolism, quorum sensing and maintenance of cell structure and cell motility in surviving S. Typhimurium. In contrast, proteins associated with oxygen stress, DNA protection, starvation, membrane rebuilding, and alternative nutrient formation were induced as the compensatory reaction. CONCLUSIONS: This study provides further evidence of the antibacterial effects of pSWCNT-Ag nanocomposites and knowledge of their mechanism of action through various protein changes. The findings may lead to the development of more effective and safe antimicrobial agents.
Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/genética , Biopelículas/efectos de los fármacos , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Nanotubos de Carbono/química , Salmonella typhimurium/efectos de los fármacos , Plata/farmacología , Animales , Antibacterianos/química , Proteínas Bacterianas/agonistas , Proteínas Bacterianas/antagonistas & inhibidores , Proteínas Bacterianas/metabolismo , Biopelículas/crecimiento & desarrollo , Embrión de Pollo , Composición de Medicamentos , Desarrollo Embrionario/efectos de los fármacos , Microbiología de Alimentos , Ontología de Genes , Humanos , Mediciones Luminiscentes , Anotación de Secuencia Molecular , Nanocompuestos/química , Polietilenglicoles/química , Proteoma/agonistas , Proteoma/antagonistas & inhibidores , Proteoma/genética , Proteoma/metabolismo , Proteómica/métodos , Percepción de Quorum/efectos de los fármacos , Percepción de Quorum/genética , Salmonella typhimurium/genética , Salmonella typhimurium/crecimiento & desarrollo , Salmonella typhimurium/metabolismo , Plata/química , Espectrometría de Masa por Láser de Matriz Asistida de Ionización DesorciónRESUMEN
We present a novel data analysis strategy which combined with subcellular fractionation and liquid chromatography-mass spectrometry (LC-MS) based proteomics provides a simple and effective workflow for global drug profiling. Five subcellular fractions were obtained by differential centrifugation followed by high resolution LC-MS and complete functional regulation analysis. The methodology combines functional regulation and enrichment analysis into a single visual summary. The workflow enables improved insight into perturbations caused by drugs. We provide a statistical argument to demonstrate that even crude subcellular fractions leads to improved functional characterization. We demonstrate this data analysis strategy on data obtained in a MS-based global drug profiling study. However, this strategy can also be performed on other types of large scale biological data.
Asunto(s)
Núcleo Celular/efectos de los fármacos , Drogas en Investigación/farmacología , Espectrometría de Masas/métodos , Microsomas/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Proteoma/análisis , Fraccionamiento Celular , Línea Celular Tumoral , Núcleo Celular/metabolismo , Expresión Génica , Perfilación de la Expresión Génica , Ensayos Analíticos de Alto Rendimiento , Humanos , Linfocitos/efectos de los fármacos , Linfocitos/metabolismo , Microsomas/metabolismo , Mitocondrias/metabolismo , Anotación de Secuencia Molecular , Proteoma/agonistas , Proteoma/antagonistas & inhibidores , Proteoma/genética , Proteómica/métodosRESUMEN
Platelets are the fundamental players in primary hemostasis, but are also involved in several pathological conditions. The remarkable advances in proteomic methodologies have allowed a better understanding of the basic physiological pathways underlying platelet biology. In addition, recent platelet proteomics focused on disease conditions, helping to elucidate the molecular mechanisms of complex and/or unknown human disorders and to find novel biomarkers for early diagnosis and drug targets. The most common and innovative proteomic techniques, both gel-based and gel-free, used in platelet proteomics will be reviewed here. A particular focus will be given to studies that used a subproteomic strategy to analyze specific platelet conditions (resting or activated), compartments (membrane, granules and microparticles) or fractions (phosphoproteome or glycoproteome). The thousands of platelet proteins and interactions discovered so far by these different powerful proteomic approaches represent a precious source of information for both basic science and clinical applications in the field of platelet biology.
Asunto(s)
Trastornos de las Plaquetas Sanguíneas/diagnóstico , Plaquetas/química , Proteómica/métodos , Biomarcadores/química , Plaquetas/efectos de los fármacos , Plaquetas/fisiología , Electroforesis de las Proteínas Sanguíneas/métodos , Glicoproteínas/química , Humanos , Fosfoproteínas/química , Fosforilación , Activación Plaquetaria , Proteoma/agonistas , Proteoma/química , Proteoma/aislamiento & purificación , Sensibilidad y Especificidad , Trombina/farmacologíaRESUMEN
We currently understand the mental effects of psychedelics to be caused by agonism or partial agonism of 5-HT(2A) (and possibly 5-HT(2C)) receptors, and we understand that psychedelic drugs, especially phenylalkylamines, are fairly selective for these two receptors. This manuscript is a reference work on the receptor affinity pharmacology of psychedelic drugs. New data is presented on the affinity of twenty-five psychedelic drugs at fifty-one receptors, transporters, and ion channels, assayed by the National Institute of Mental Health-Psychoactive Drug Screening Program (NIMH-PDSP). In addition, comparable data gathered from the literature on ten additional drugs is also presented (mostly assayed by the NIMH-PDSP). A new method is introduced for normalizing affinity (K(i)) data that factors out potency so that the multi-receptor affinity profiles of different drugs can be directly compared and contrasted. The method is then used to compare the thirty-five drugs in graphical and tabular form. It is shown that psychedelic drugs, especially phenylalkylamines, are not as selective as generally believed, interacting with forty-two of forty-nine broadly assayed sites. The thirty-five drugs of the study have very diverse patterns of interaction with different classes of receptors, emphasizing eighteen different receptors. This diversity of receptor interaction may underlie the qualitative diversity of these drugs. It should be possible to use this diverse set of drugs as probes into the roles played by the various receptor systems in the human mind.